Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ROSETTA- A Global Registry On Second gEneration and Long-acting inTegrase inhibiTor fAilures

NCT06706986 is registered in ClinicalTrials.gov with UMC Utrecht as lead sponsor.

NCT NCT06706986
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06706986 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ROSETTA- A Global Registry On Second gEneration and Long-acting inTegrase inhibiTor fAilures
Lead sponsor
UMC Utrecht
Phase
Observational
Overall status
Enrolling by invitation
Start date
September 1, 2023
Completion date
September 1, 2025
Enrollment
250 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv, therapy failure